- Collaboration to leverage AbbVie's eye care expertise and Ripple's innovative drug delivery platform to develop next-generation sustained release drug delivery implants for the treatment of glaucoma ...
Rob Speyer, Chief Executive Officer of Tishman Speyer, shares his view on Shanghai's 2035 outlook. He said: "I believe that Shanghai can harness the power of a technology-driven paradigm shift over ...